Topics

EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative ...

06:17 EDT 30 Apr 2019 | BioMedReports - Blog

SALT LAKE CITY, April 30, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative ...

NEXT ARTICLE

More From BioPortfolio on "EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative ..."

Quick Search